Search for: "AstraZeneca Pharmaceuticals, L.P. v Apotex Corp."
Results 1 - 5
of 5
Sorted by Relevance
|
Sort by Date
10 Feb 2012, 10:56 am
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
10 Feb 2012, 10:56 am
In AstraZeneca Pharmaceuticals, L.P. v Apotex Corp., the Court held for defendant generic manufacturers on the grounds that Plaintiff failed to state a 35 U.S.C. 271(e)(2) claim based on defendants’ existing ANDA filings, and claims premised on presumed future labeling amendments were not ripe for adjudication. [read post]
25 Aug 2010, 12:37 am
Apotex Corp. et al. [read post]
21 Nov 2007, 5:21 am
AstraZeneca Pharmacerticals, L.P., 958 So. 2d 1054 (Fla. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
